These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

500 related items for PubMed ID: 31429616

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Risk factors for extended-spectrum β-lactamase-producing Escherichia coli urinary tract infection in the community in Denmark: a case-control study.
    Søgaard M, Heide-Jørgensen U, Vandenbroucke JP, Schønheyder HC, Vandenbroucke-Grauls CMJE.
    Clin Microbiol Infect; 2017 Dec; 23(12):952-960. PubMed ID: 28377310
    [Abstract] [Full Text] [Related]

  • 24. Increased community-acquired upper urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in children and the efficacy of flomoxef and cefmetazole.
    Horie A, Nariai A, Katou F, Abe Y, Saito Y, Koike D, Hirade T, Ito T, Wakuri M, Fukuma A.
    Clin Exp Nephrol; 2019 Nov; 23(11):1306-1314. PubMed ID: 31428892
    [Abstract] [Full Text] [Related]

  • 25. Prevalence, antibiotic sensitivity pattern and genetic analysis of extended spectrum beta lactamase producing Escherichia coli and Klebsiella spp among patients with community acquired urinary tract infection in Galle district, Sri Lanka.
    Priyadharshana U, Piyasiri LB, Wijesinghe C.
    Ceylon Med J; 2019 Dec 31; 64(4):140-145. PubMed ID: 32120467
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Community-acquired urinary tract infections due to extended-spectrum β -lactamase-producing organisms in United Arab Emirates.
    Ranjan Dash N, Albataineh MT, Alhourani N, Khoudeir AM, Ghanim M, Wasim M, Mahmoud I.
    Travel Med Infect Dis; 2018 Dec 31; 22():46-50. PubMed ID: 29409967
    [Abstract] [Full Text] [Related]

  • 31. The risk factors, antimicrobial resistance patterns, and outcomes associated with extended-spectrum β-lactamases-Producing pathogens in pediatric urinary tract infection.
    He XT, Chang CN, Yu CH, Wang CC.
    Pediatr Neonatol; 2024 May 31; 65(3):242-248. PubMed ID: 37951832
    [Abstract] [Full Text] [Related]

  • 32. Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy.
    Meier S, Weber R, Zbinden R, Ruef C, Hasse B.
    Infection; 2011 Aug 31; 39(4):333-40. PubMed ID: 21706226
    [Abstract] [Full Text] [Related]

  • 33. Extended-spectrum beta-lactamase Escherichia coli and Klebsiella pneumoniae urinary tract infections.
    Vachvanichsanong P, McNeil EB, Dissaneewate P.
    Epidemiol Infect; 2020 Dec 17; 149():e12. PubMed ID: 33327984
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Clinical and economic impact of urinary tract infections caused by ESBL-producing Escherichia coli requiring hospitalization: A matched cohort study.
    Esteve-Palau E, Solande G, Sánchez F, Sorlí L, Montero M, Güerri R, Villar J, Grau S, Horcajada JP.
    J Infect; 2015 Dec 17; 71(6):667-74. PubMed ID: 26380898
    [Abstract] [Full Text] [Related]

  • 36. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
    Cho YH, Jung SI, Chung HS, Yu HS, Hwang EC, Kim SO, Kang TW, Kwon DD, Park K.
    Int Urol Nephrol; 2015 Jul 17; 47(7):1059-66. PubMed ID: 26026972
    [Abstract] [Full Text] [Related]

  • 37. Epidemiology and risk factors for isolation of Escherichia coli producing CTX-M-type extended-spectrum β-lactamase in a large U.S. Medical Center.
    Hayakawa K, Gattu S, Marchaim D, Bhargava A, Palla M, Alshabani K, Gudur UM, Pulluru H, Bathina P, Sundaragiri PR, Sarkar M, Kakarlapudi H, Ramasamy B, Nanjireddy P, Mohin S, Dasagi M, Datla S, Kuchipudi V, Reddy S, Shahani S, Upputuri V, Marrey S, Gannamani V, Madhanagopal N, Annangi S, Sudha B, Muppavarapu KS, Moshos JA, Lephart PR, Pogue JM, Bush K, Kaye KS.
    Antimicrob Agents Chemother; 2013 Aug 17; 57(8):4010-8. PubMed ID: 23752516
    [Abstract] [Full Text] [Related]

  • 38. Infections due to Escherichia coli producing extended-spectrum beta-lactamase among hospitalised patients: factors influencing mortality.
    Peña C, Gudiol C, Calatayud L, Tubau F, Domínguez MA, Pujol M, Ariza J, Gudiol F.
    J Hosp Infect; 2008 Feb 17; 68(2):116-22. PubMed ID: 18226420
    [Abstract] [Full Text] [Related]

  • 39. Childhood urinary tract infection caused by extended-spectrum β-lactamase-producing bacteria: Risk factors and empiric therapy.
    Uyar Aksu N, Ekinci Z, Dündar D, Baydemir C.
    Pediatr Int; 2017 Feb 17; 59(2):176-180. PubMed ID: 27501161
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.